The three widely distributed peptides derived from prosomatostatin are the original neurohormone somatostatin-14, somatostatin-28, and somatostatin-28(1-12), which are all derived from the COOH terminus of the precursor. Recently a decapeptide derived from the NH2 terminus of the prohormone has been identified in extracts of rat gastric antrum and named antrin. Data now show that in both rats and humans this new molecular form is concentrated in the D cell of the gastrointestinal mucosa together with somatostatin-28(1-12). The highest concentration of antrin immunofluorescent cells is located in the mucosa of the gastric antrum. Ultrastructural studies performed on pyloric D cells using the protein A-gold technique reveals that antrin is present in the same secretory granules as somatostatin-28(1-12) and detectable in one-third of all secretory granules. Acid extracts of rat hepatic portal plasma contain a peptide similar or identical to antrin, indicating that the antral decapeptide circulates in blood.
Introduction
The notion that peptide hormones are derived from precursor proteins by posttranslational modification is now well recognized (1) . During the maturation process several peptides may be generated together with the hormone. These other peptides, often called cryptic peptides, are important for three reasons: (a) their presence provides information on the processing events, (b) some are better markers for a given peptidergic system than the hormone itself, and (c) among these peptides, a few could serve a biological role. After a new molecular form has been identified in a given tissue extract, several questions are raised, such as whether it may represent an artifact of extraction. If the peptide is not produced artifactually it is important to know the cell type from which it originates and whether it can be secreted by these cells.
Somatostatin is a bioactive peptide of 14 or 28 amino acids that generally acts as a paninhibitor in the neuroendocrine system. It is derived from the COOH-terminal end of a 10-kD precursor protein, prosomatostatin (2) (3) (4) (5) (Fig. 1) . We have recently isolated a peptide from rat stomach that corresponds to the first 10 amino acids at the NH2 terminus of mammalian prosomatostatin (6) . In the rat, the highest concentration of the decapeptide is present in the gastric antrum, hence the proposed name antrin. It is presently assumed that antrin is formed after cleavage at a monobasic site very similar to that leading to formation of somatostatin-28 and somatostatin-28 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . In the present work we provide the first immunocytochemical data on the cellular and ultrastructural localization of antrin and compare it with somatostatin-28(1-12), an excellent marker of the prosomatostatin system in tissue (7, 8) . Evidence is also presented for the antral decapeptide circulating in hepatic portal blood in rats.
Methods

Antisera
To obtain specific antibodies that recognize only antrin, not prosomatostatin or any of the other prosomatostatin-derived peptides, one must direct the formation of gamma globulin toward the COOH terminus of antrin. This was achieved by immunizing rabbits with a mixture of synthetic antrin and methylated BSA or with the analogue
[TYR3]antrin (3) (4) (5) (6) (7) (8) (9) (10) coupled to BSA as described previously for several other peptides (9) . The immuno plasma generated by the first method ( Fig. 2) (Fig. 3 A) . All antrin immunofluorescent cells examined reacted also with S320 antibody. The staining for antrin was more sparse than that for somatostatin-28(1-12) which, when present, produced a diffuse cytoplasmic staining (compare Fig. 3, A and B) . The same experiments performed in human fetal gastric tissue yielded similar results for both antrin and somatostatin-28(1-12) immunostaining (Fig. 3, C  and D) . Control of specificity showed that among the peptides used to adsorb the anti-antrin serum before the immunolabeling, only antrin abolished the staining.
At the ultrastructural level antrin immunoreactivity, local- antrin(3-10) with 20 jig chloramine T during 38 s followed by addition of 75 ,ug sodium metabisulfite and I mg human serum albumin. The label was purified on carboxymethyl cellulose (CM 52; Whatman Laboratory Products, Inc., Clifton, NJ) using 0.04 M ammonium acetate, pH 4.6, as the elution buffer. Net binding of label to antibody was 31% after 44 h incubation at 4°C in RIA buffer (9) . The specificity studies represented ized by pAg, was observed over the secretory granules. Labeled granules frequently coexisted with granules devoid of immunolabeling (Fig. 4, A and C) . Quantitative evaluation of antrin-positive granules showed that they represented 33% of the population of secretory granules in rat D cells and 15% in human fetal D cells.
Comparing serial sections, one incubated with anti-antrin and the other with anti-somatostatin-28(1-12), it was found that the secretory granules containing antrin also contained somatostatin-28(1-12) (Fig. 4, A-D) . By contrast, many somatostatin-positive granules do not contain antrin. Inasmuch as the antiserum recognizes the COOH terminus of prosomatostatin 1-10 (antrin) it appears that the processing of prosomatostatin to antrin occurs in only a subpopulation of the granules that process prosomatostatin to prosomatostatin-28 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Antrin could be a late cleavage product, occurring only in "old" granules, and never be secreted. When extract of rat hepatic portal plasma was subjected to gel permeation chromatography, it was found that a single peak of immunoreactivity eluted in a zone compatible with a peptide the size of antrin (-1,200 mol wt) (Fig. 5 ).
Discussion
The findings obtained with a specific antibody population directed toward antrin indicate (a) that the decapeptide is present in secretory granules that also contain somatostatin-28 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , and (b) that it is detectable in only a fraction of somatostatin-containing granules in a subpopulation of somatostatin-producing cells. This suggests differential precursor processing or product stability within the granules, and antrin could thus be a marker for the presence of specific cleavage enzymes.
Antrin cannot be detected by immunohistochemistry in gastric nerves, nor can it be detected in the D cells of the pancreas. This restricted tissue distribution, namely that the endocrine cells of the stomach are the predominant site of antrin accumulation, suggests that the measurement of antrin in blood may represent a means by which to evaluate specifically the response of the gastric D cell during digestion. Together with the demonstration of this peptide in the portal circulation, it also suggests that antrin acts as a hormone during digestion. The Figure 5 . Sephadex G-75 gel permeation chromatography of an acid extract of 78 ml rat portal plasma. Hepatic portal blood was collected in cold heparinized syringes from adult Sprague-Dawley rats fed ad lib. After centrifugation at 12,800 g for 2 min at 40C the plasma was added to 2 M acetic acid (1 vol vation from catfish to man in the region of prosomatostatin corresponding to antrin argues in favor of a biological role for that molecule (5) .
